AAAAAA
Results:
1-16
|
Results: 16
Authors:
CURE H
KRAKOWSKI I
ADENIS A
TUBIANA N
KERBRAT P
ROCHE H
CHEVALLIER B
LENTZ MA
FUMOLEAU P
CHOLLET P
Citation: H. Cure et al., RESULTS OF A PHASE-II TRIAL WITH 2ND-LINE CYSTEMUSTINE AT 60 MG M(2) IN ADVANCED SOFT-TISSUE SARCOMA - A TRIAL OF THE EORTC EARLY CLINICAL-STUDIES GROUP/, European journal of cancer, 34(3), 1998, pp. 422-423
Authors:
PICCART MJ
GREEN J
LACAVE AJ
REED N
BENEDETTIPANICI P
LENTZ MA
SELVAIS R
CURRAN D
PINEL MC
VERGOTE I
Citation: Mj. Piccart et al., OXALIPLATIN - AN ACTIVE COMPOUND IN PLATINUM PRETREATED OVARIAN-CANCER PATIENTS - FINAL RESULTS OF A RANDOMIZED PHASE-II TRIAL BY THE EORTC- GYNECOLOGICAL CANCER COOPERATIVE GROUP, Annals of oncology, 9, 1998, pp. 314-314
Authors:
DEGARDIN M
OLIVEIRA J
GEOFFROIS L
ROLLAND F
ARMAND JP
BASTIT P
CHAUVERGNE J
FARGEOT P
VANGLABBEKE M
LENTZ MA
TRESCA P
BOUDILLET J
FUMOLEAU P
CAPPELAERE P
Citation: M. Degardin et al., AN EORTC-ECSG PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/, Annals of oncology, 9(10), 1998, pp. 1103-1107
Authors:
PAWINSKI A
VANOOSTEROM AT
DEWIT R
FOSSA S
CROLES J
SVEDBERG A
LENTZ MA
DEMULDER PHM
Citation: A. Pawinski et al., AN EORTC PHASE-II STUDY OF THE EFFICACY AND SAFETY OF LINOMIDE IN THETREATMENT OF ADVANCED RENAL-CELL CARCINOMA, European journal of cancer, 33(3), 1997, pp. 496-499
Authors:
UROSEVIC V
CHOLLET P
ADENIS A
CHAUVERGNE J
FARGEOT P
ROCHE H
KERBRAT P
LENTZ MA
FUMOLEAU P
CHEVALLIER B
Citation: V. Urosevic et al., RESULTS OF A PHASE-II TRIAL WITH CYSTEMUSTINE IN ADVANCED MALIGNANT-MELANOMA - A TRIAL OF THE EORTC CLINICAL SCREENING GROUP, European journal of cancer, 32A(1), 1996, pp. 181-182
Authors:
MANEGOLD C
DRINGS P
PAWINSKI A
LENTZ MA
VANGLABBEKE M
VANZANDWIJK N
BACHMANN P
SCHNAARS Y
SKACEL Z
ZATLOUKAL P
DOLENSKY J
JACKEVICIUS A
PETRUZELKA L
GIACCONE G
Citation: C. Manegold et al., ORAL IFOSFAMIDE MESNA VERSUS INTRAVENOUS IFOSFAMIDE/MESNA IN NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-II TRIAL OF THE EORTC LUNG-CANCER COOPERATIVE GROUP/, Annals of oncology, 7(6), 1996, pp. 637-639
Authors:
DIERAS V
CHEVALLIER B
KERBRAT P
KRAKOWSKI I
ROCHE H
MISSET JL
LENTZ MA
AZLI N
MURAWSKY M
RIVA A
POUILLART P
FUMOLEAU P
Citation: V. Dieras et al., A MULTICENTER PHASE-II STUDY OF DOCETAXEL 75 MG M(-2) AS FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED BREAST-CANCER - REPORT OF THE CLINICAL SCREENING GROUP OF THE EORTC, British Journal of Cancer, 74(4), 1996, pp. 650-656
Authors:
CAPPELAERE P
LENTZ MA
DEGARDIN M
CHAUVERGNE J
MAYER F
CHOLLET P
CHEVALLIER B
Citation: P. Cappelaere et al., PHASE-II STUDY OF CYSTEMUSTINE IN ADVANCED HEAD AND NECK-CANCER - A TRIAL OF THE EORTC CLINICAL SCREENING GROUP, European journal of cancer. Part B, Oral oncology, 31B(2), 1995, pp. 151-152
Authors:
KLEEBERG UR
ENGEL E
ISRAELS P
BROCKER EB
TILGEN W
KENNES C
GERARD B
LEJEUNE F
GLABBEKE MV
LENTZ MA
Citation: Ur. Kleeberg et al., PALLIATIVE THERAPY OF MELANOMA PATIENTS WITH FOTEMUSTINE - INVERSE RELATIONSHIP BETWEEN TUMOR LOAD AND TREATMENT EFFECTIVENESS - A MULTICENTER PHASE-II TRIAL OF THE EORTC-MELANOMA COOPERATIVE GROUP (MCG), Melanoma research, 5(3), 1995, pp. 195-200
Authors:
BRAUSI M
JONES WG
FOSSA SD
DEMULDER PHM
DROZ JP
LENTZ MA
VANGLABBEKE M
PAWINSKI A
Citation: M. Brausi et al., HIGH-DOSE EPIRUBICIN IS EFFECTIVE IN MEASURABLE METASTATIC PROSTATE-CANCER - A PHASE-II STUDY OF THE EORTC GENITOURINARY GROUP, European journal of cancer, 31A(10), 1995, pp. 1622-1626
Authors:
CHAUVERGNE J
KERBRAT P
ADENIS A
CHOLLET P
FARGEOT P
PUJADELAURAINE E
DIERAS V
MADELMONT JC
LENTZ MA
TOULOUSE C
CHEVALLIER B
Citation: J. Chauvergne et al., PHASE-II STUDY OF CYSTEMUSTINE IN ADVANCED RENAL-CANCER, European journal of cancer, 31A(1), 1995, pp. 130-131
Authors:
CHEVALLIER B
FUMOLEAU P
KERBRAT P
DIERAS V
ROCHE H
KRAKOWSKI I
AZLI N
BAYSSAS M
LENTZ MA
VANGLABBEKE M
Citation: B. Chevallier et al., DOCETAXEL IS A MAJOR CYTOTOXIC DRUG FOR THE TREATMENT OF ADVANCED BREAST-CANCER - A PHASE-II TRIAL OF THE CLINICAL SCREENING COOPERATIVE GROUP OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER, Journal of clinical oncology, 13(2), 1995, pp. 314-322
Authors:
DEGARDIN M
ARMAND JP
CHEVALLIER B
CAPPELAERE P
LENTZ MA
DAVID M
ROCHE H
Citation: M. Degardin et al., A CLINICAL SCREENING COOPERATIVE GROUP PHASE-II EVALUATION OF LOBAPLATIN (ASTA D-19466) IN ADVANCED HEAD AND NECK-CANCER, Investigational new drugs, 13(3), 1995, pp. 253-255
Authors:
VERMORKEN JB
BOLIS G
VANRIJSWIJK REN
KOBIERSKA A
CHEVALLIER B
VANDERBURG MEL
ZANABONI F
LENTZ MA
BURGER CW
KENEMANS P
PINEDO HM
Citation: Jb. Vermorken et al., HIGH-DOSE INTENSITY REGIMENS WITH EPIRUBICIN IN OVARIAN-CANCER, Seminars in oncology, 21(1), 1994, pp. 17-22
Authors:
KLEEBERG UR
ENGEL E
BROCKER EB
AVRIL F
ISRAELS P
WEISS J
KANGAS L
VANGLABBEKE M
LENTZ MA
Citation: Ur. Kleeberg et al., EFFECT OF TOREMIFENE IN PATIENTS WITH METASTATIC MELANOMA - A PHASE-II STUDY OF THE EORTC-MELANOMA-COOPERATIVE-GROUP, Melanoma research, 3(2), 1993, pp. 123-126
Authors:
KERBRAT P
ADENIS A
REBATTU P
ROCHE H
CHEVALLIER B
CHOLLET P
KRAKOWSKI I
LENTZ MA
FUMOLEAU P
Citation: P. Kerbrat et al., PHASE-II STUDY OF CYSTEMUSTINE IN METASTATIC COLORECTAL-CARCINOMA - ATRIAL OF THE EORTC CLINICAL SCREENING GROUP, European journal of cancer, 29A(11), 1993, pp. 1597-1599
Risultati:
1-16
|